-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AUC-033 in Epilepsy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AUC-033 in Epilepsy Drug Details: AUC-033 is under development for the treatment of epilepsy. Report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AUC-033 in Epilepsy
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AUC-033 in Epilepsy Drug Details: AUC-033 is under development for the treatment of epilepsy....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acetylleucine in Sandhoff Disease (Jatzkewitz-Pilz Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acetylleucine in Sandhoff Disease (Jatzkewitz-Pilz Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Acetylleucine in Sandhoff Disease (Jatzkewitz-Pilz Syndrome)Drug Details:Acetylleucine (IB-1001) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dezapelisib in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dezapelisib in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Dezapelisib in Chronic Lymphocytic Leukemia (CLL) Drug Details:Dezapelisib (INCB-40093) is under...
-
Company Profile
Acme United Corp – Company Profile
Acme United Corp (AUC) is a provider of cutting, measuring and safety products. The company’s products include, rulers, scissors, paper trimmers, pencil sharpeners, lettering products, math tools, knives, cutting tools, industrial stations and refills, emergency medical travel, and recreational kits. It also offers first aid kits, kit refills, emergency and disaster kits, hearing, eye, and head protection, ergonomic supports and braces, and over-the-counter medications. AUC provides these products under various brands, including Westcott, Clauss, Camillus, Pac-Kit, First Aid Only, Spill...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AUC-033
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AUC-033 Drug Details AUC-033 is under development for the treatment of epilepsy. Report Coverage...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – timolol maleate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry timolol maleate Drug Details Timolol maleate (AUC-029) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – lamotrigine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry lamotrigine Drug Details Lamotrigine (AUC-025, ET-105) is under development for the treatment of partial...